WHO ICTRP trial
EndoBarrier® Gastrointestinal Liner Diabetes Trial
ISRCTN30845205 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN30845205 |
|---|---|
| Public title | EndoBarrier® Gastrointestinal Liner Diabetes Trial |
| Scientific title | A randomised controlled trial of a duodenal sleeve bypass device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes |
| Primary sponsor | Imperial College London (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;England |
| Conditions | Topic: Diabetes; Subtopic: Type 2; Disease: Device studies, Diabetic Control, Hypoglycemia, Metabolic, Nutrition, Obesity Nutritional, Metabolic, Endocrine |
| Interventions | EndoBarrier or Standard Medical Therapy: Subject will be either having the EndoBarrier device or standard medical therapy (medication, diet and exercise) treatment for 12 months followed by another 12 months follow-up period. In an attempt… |
| Registration date | Sep 26, 2014 |
| Target size | 160 |
| Secondary IDs | NCT02459561;17212 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: